Department of Biostatistics (P.B.), University of Washington, Seattle, Washington 98115; Division of Endocrinology, Kaiser Permanente of Georgia and the Division of Endocrinology (J.I.B.), Emory University School of Medicine, Atlanta, Georgia 30096; Geriatric Research Education & Clinical Center (H.A.F.), Veterans Affair Medical Center, Minneapolis, Minnesota 55417; Department of Medicine (J.A.R.), University of California, Davis, Sacramento, California; Department of Epidemiology (J.A.C.), Graduate School of Public Health, University of Pittsburgh, Pittsburgh 15261, Pennsylvania; and Department of Epidemiology (A.L.F.), University of Washington, Seattle, Washington 98115.
J Clin Endocrinol Metab. 2014 Nov;99(11):4116-23. doi: 10.1210/jc.2014-2409. Epub 2014 Aug 22.
Microvascular disease is a leading cause of cognitive impairment. Approximately 50% of people with a hip fracture have cognitive impairment.
We tested the hypothesis that microvascular diseases of the brain (lacunar infarcts and white matter disease [WMD]), kidney (albuminuria [≥ 30 mg/g creatinine] and albumin creatinine ratio [ACR]), and eye (retinal vascular disorders) attenuate the association of cognitive impairment with hip fracture risk.
The Cardiovascular Health Cognition Study.
Three thousand, one-hundred six participants (mean age, ∼ 79 y; 8.84 y median follow-up) with cognitive testing. Subsets received ACR testing (n=2389), brain magnetic resonance imaging scans (n = 2094), and retinal photography (n = 1098).
Incident hip fracture.
There were 488 participants (16%) with mild cognitive impairment (MCI) and 564 (18%) with dementia. There were 337 incident hip fractures, of which 19% occurred in participants with MCI and 26% in participants with dementia. Adjusted hazard ratios (HR) and 95% confidence interval for hip fracture in participants with MCI were 2.45 (1.67-3.61) and for dementia 2.35 (1.57-3.52). With doubling of ACR, the HR for fracture was attenuated in participants with dementia compared with participants with normal cognition [interaction HR 0.70 (0.55-0.91)]. No such effect was found in participants with MCI. Albuminuria, lacunar infarcts, WMD, and retinal vascular disease (RVD) did not modify the association of dementia or MCI with hip fracture risk.
ACR attenuates part of the risk of hip fracture in people with dementia, suggesting that these disorders share a common pathogenesis.
微血管疾病是认知障碍的主要原因。大约 50%的髋部骨折患者存在认知障碍。
我们检验了如下假设,即脑(腔隙性梗死和脑白质疾病[WMD])、肾(白蛋白尿[≥30mg/g 肌酐]和白蛋白肌酐比[ACR])和眼(视网膜血管疾病)的微血管疾病会削弱认知障碍与髋部骨折风险之间的关联。
心血管健康认知研究。
3106 名参与者(平均年龄约 79 岁;中位随访时间 8.84 年)进行认知测试。部分参与者接受 ACR 测试(n=2389)、脑磁共振成像扫描(n=2094)和视网膜摄影(n=1098)。
髋部骨折的发生。
有 488 名参与者(16%)患有轻度认知障碍(MCI),564 名(18%)患有痴呆症。有 337 例髋部骨折发生,其中 19%发生在 MCI 参与者中,26%发生在痴呆症参与者中。MCI 参与者髋部骨折的校正后风险比(HR)和 95%置信区间为 2.45(1.67-3.61),痴呆症为 2.35(1.57-3.52)。在 ACR 加倍的情况下,与认知正常的参与者相比,痴呆症参与者的骨折风险降低(交互 HR 0.70[0.55-0.91])。在 MCI 参与者中未发现这种影响。白蛋白尿、腔隙性梗死、WMD 和视网膜血管疾病(RVD)并未改变痴呆症或 MCI 与髋部骨折风险之间的关联。
ACR 削弱了痴呆症患者髋部骨折的部分风险,这表明这些疾病具有共同的发病机制。